Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013

Brain and Development

Volumn 36, Issue 9, 2014, Pages 739-751

  Pavone, Piero ^a   Striano, Pasquale ^b   Falsaperla, Raffaele ^a   Pavone, Lorenzo ^a   Ruggieri, Martino ^c  

^a University Hospital 'Policlinico Vittorio Emanuele'   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Genetics; Hypsarrhythmia; Infantile spasms; Treatment; West syndrome

Indexed keywords

CORTICOTROPIN; FELBAMATE; LAMOTRIGINE; PYRIDOXINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AUTISM; BRAIN DEVELOPMENT; CLINICAL FEATURE; CONGENITAL MALFORMATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; FOREBRAIN; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HYPSARRHYTHMIA; INFANTILE SPASM; KETOGENIC DIET; MOTOR DYSFUNCTION; PATHOGENESIS; PHENOTYPE; PROGNOSIS; REVIEW; SEIZURE; SYSTEMATIC REVIEW; BRAIN; COGNITION; INFANT; PATHOPHYSIOLOGY; SPASMS, INFANTILE;

BRAIN; COGNITION; HUMANS; INFANT; SPASMS, INFANTILE;

EID: 84910616272     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2013.10.008     Document Type: Review

References (109)

1. West WJ. On a peculiar form of infantile convulsions. Lancet 1841;1:724-5.
2. Pies NJ, Beardsmore CW. West & West syndrome-a historical sketch about the eponymous doctor, his work and his family. Brain Dev 2003;25:84-101.
3. Lux AL. West & son: the origins of West syndrome. Brain Dev 2001;23:443-6.
4. Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol 2011;45:355-67.
5. Gibbs FA, Gibbs EL. Atlas of electroencephalography. Epilepsy vol II. Cambridge MA: Addison-Wesley, 1952: p. 2.
6. Sorel L, Dusaucy-Bauloye A. Findings in 21 cases of Gibbs' hypsarrhythmia; spectacular effectiveness of ACTH. Acta Neurol Psychiatr Belg 1958;58:130-41.
7. Wong M, Trevethan E. Infantile spasms. Pediatr Neurol 2001;24:89-98.
8. Dulac O, Chugani HT, Dalla Bernardina BD. Overview. In: Dulac O, Chugani HT, Dalla Bernardina B, eds. Infantile spasms and West syndrome. London: WB Saunders 1994: pp. 1-5.
9. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 2001;23:539-41.
10. Cowan LD, Hudson LS. The epidemiology and natural history of infantile spasms. J Child Neurol 1991;6:355-64.
11. Ludvigsson P, Olafsson E, Siguroardottir S, Hauser WA. Epidemiologic features of infantile spasms in Iceland. Epilepsia 1994;35:820-5.
12. Kellaway P, Hrachovy RA, Frost Jr JD, Zion T. Precise characterization and quantification of infantile spasms. Ann Neurol 1979;6:214-8.
13. Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics 1982;13: 14-23.
14. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:3 89-99.
15. Commission and Classification and Terminology of the International, League Against Epilepsy. Workshop on infantile spasms. Epilepsia 1992;33:195.
16. Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the west delphi group. Epilepsia 2004;45:1416-28.
17. Caraballo RH, Fejerman N, Dalla Bernardina BD, Ruggieri V, Cersósimo R, Medina C, et al. Epileptic spasms in clusters without hypsarrhythmia in infancy. Epileptic Disord 2003;5: 109-13.
18. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology 2005-2009. Epilepsia 2010;51:676-85.
19. Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, et al. Practice parameter: medical treatment of infantile spasms: report of the American academy of neurology and the child neurology society. Neurology 2004;62: 1668-81.
20. Lux AL. Latest American and European updates on infantile spasms. Curr Neurol Neurosci Rep 2013;13:334-41.
21. Go CY, Mackay MT, Weiss SK, Stephens D, Adams-Webber T, Ashwal S, et al. Evidence-based guideline update: medical treatment of infantile spasms: report of the guideline development subcommittee of the American academy of neurology and the practice committee of the child neurology society. Neurology 2012;78:1974-80.
22. Sidenvall R, Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia 1995;36:572-4.
23. Trevathan E, Murphy CC, Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 1999;40:748-51.
24. Rantala H, Putkonen T. Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia 1999;40:286-9.
25. Caraballo RH, Ruggieri V, Gonzales G, Cersosimo R, Gamboni B, Rey A, et al. Infantile spams without hypsarrhythmia: a study of 16 cases. Seizure 2011;20:197-202.
26. Kurokawa T, Goya N, Fukuyama Y, Suzuki M, Seki T, Ohtahara S. West syndrome and Lennox-Gastaut syndrome: a survey of natural history. Pediatrics 1980;65:81-8.
27. King DW, Dyken PR, Spinks Jr IL, Murvin AJ. Infantile spasms: ictal phenomena. Pediatr Neurol 1985;1:213-8.
28. Dulac O. What is West syndrome? Brain Dev 2001;23:447-52.
29. Hakamada S, Watanabe K, Hara K, Miyazaki S. Brief atonia associated with electroencephalographic paroxysm in an infant with infantile spasms. Epilepsia 1981;22:285-8.
30. Blume WT, Lüders HO, Mizrahi E, Tassinari C, Van Emde Boas W, Engel Jr J. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42: 1212-8.
31. Gobbi G, Bruno L, Pini A, Giovanardi Rossi P, Tassinari CA. Periodic spasms: an unclassified type of epileptic seizure in childhood. Dev Med Child Neurol 1987;29:766-75.
32. Lux AL. Is hypsarrhythmia a form of non-convulsive status epilepticus in infants? Acta Neurol Scand Suppl 2007;186:37-44.
33. Lombroso CT, Fejerman N. Benign myoclonus of early infancy. Ann Neurol 1977;1:138-43.
34. Dravet C, Giraud N, Bureau M, Roger J, Gobbi G, Dalla Bernardina B. Benign myoclonus of early infancy or benign nonepileptic infantile spasms. Neuropediatrics 1986;17:33-8.
35. KossoffEH. Infantile spasms. Neurologist 2010;2:69-75.
36. Guggenheim MA, Frost Jr JD, Hrachovy RA. Time interval from a brain insult to the onset of infantile spasms. Pediatr Neurol 2008;38:34-7.
37. Osborne JP, Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, et al. The underlying etiology of infantile spams (West syndrome): unformation from the United Kingdom infantile spasms study (UKISS) on contemporary causes and their classification. Epilepsia 2010;516:2168-74.
38. Suleiman J, Brenner T, Gill D, Troedson C, Sinclair AJ, Brilot F. Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol 2011;53:1058-60.
39. Pavone L, Mollica F, Incorpora G, Pampiglione G. Infantile spasms syndrome in monozygotic twins. Arch Dis Child 1980; 55:870-2.
40. Pavone L, Mollica F, Incorpora G, Pampiglione G. Infantile spasms syndrome in monozygotic twins. A 7-year follow-up. Ital J Neurol Sci 1985;6(4):503-6.
41. Coppola G, Grosso S, Verrotti A, D'Aniello A, Pascotto A. Simultaneous onset of infantile spasms in monozygotic twins. Pediatr Neurol 2010;43:127-30.
42. Rugtveit J. X-linked mental retardation and infantile spasms in two brothers. Dev Med Child Neurol 1986;28:544-6.
43. Dulac O, Feingold J, Plouin P, Chiron C, Pajot N, Ponsot G. Genetic predisposition to West syndrome. Epilepsia 1993;34: 732-7.
44. Claes S, Devriendt K, Lagae L, Ceulemans B, Dom L, Casaer P, et al. The X-linked infantile spasms syndrome (MIM 308350) maps to Xp11.4-Xpter in two pedigrees. Ann Neurol 1997;42: 360-4.
45. Ronce N, Raynaud M, Toutain A, Moizard MP, Colleaux L, Gendrot C, et al. Evidence for a new X-linked mental retardation gene in Xp21-Xp22: clinical and molecular data in one family. Am J Med Genet 1999;83:132-7.
46. Reiter E, Tiefenthaler M, Freillinger M, Bernert G, Seidl R, Hauser E. Familial idiopathic West syndrome. J Child Neurol 2000;15:249-52.
47. Tao J, Van Esch H, Hagedorn-Greiwe M, Hoffmann K, Moser B, Raynaud M, et al. Mutations in the X-linked cyclindependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 2004;75:1149-54.
48. Kato M, Saitoh S, Kamei A, Shiraishi H, Ueda Y, Akasaka M, et al. A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppressionburst pattern (Ohtahara syndrome). Am J Hum Genet 2007; 81:361-6.
49. Hemminki K, Li X, Johansson SE, Sundquist K, Sundquist J. Familial risks for epilepsy among siblings based on hospitalizations in Sweden. Neuroepidemiology 2006;27:67-73.
50. Kato M, Das S, Petras K, Sawaishi Y, Dobyns WB. Polyalanine expansion of ARX associated with cryptogenic West syndrome. Neurology 2003;61:267-76.
51. Kato M. A new paradigm for West syndrome based on molecular and cell biology. Epilepsy Res 2006;70(Suppl. 1): S87-95.
52. Scheffer IE, Wallace RH, Phillips FL, Hewson P, Reardon K, Parasivam G, et al. X-linked myoclonic epilepsy with spasticity and intellectual disability: mutation in the homeobox gene ARX. Neurology 2002;59:348-56.
53. Guerrini R, Moro F, Kato M, Barkovich AJ, Shiihara T, McShane MA, et al. Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology 2007; 69:427-33.
54. Wallerstein R, Sugalski R, Cohn L, Jawetz R, Friez M. Expansion of the ARX spectrum. Clin Neurol Neurosurg 2008;110:631-4.
55. Giordano L, Sartori S, Russo S, Accorsi P, Galli J, Tiberti A, et al. Familial Ohtahara syndrome due to a novel ARX gene mutation. Am J Med Genet A 2010;152A:3133-7.
56. Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OL, Archer H, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 2004;75:1079-93.
57. Elia M, Falco M, Ferri R, Spalletta A, Bottitta M, Calabrese G, et al. CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology 2008;71:997-9.
58. Masliah-Plachon J, Auvin S, Nectoux J, Fichou Y, Chelly J, Bienvenu T. Somatic mosaicism for a CDKL5 mutation as an epileptic encephalopathy in males. Am J Med Genet A 2010; 152A:2110-1.
59. Saletti V, Canafoglia L, Cambiaso P, Russo S, Marchi M, Riva D. A CDKL5 mutated child with precocious puberty. Am JMed Genet A 2009;149A:1046-51.
60. Russo S, Marchi M, Cogliati F, Bonati MT, Pintaudi M, Veneselli E, et al. Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes. Neurogenetics 2009;10:241-50.
61. Ruggieri M, Pavone P, Scapagnini G, RomeoL, Lombardo I, Li Volti G, et al. The arystaless gene (ARX): one gene for many interneuronopathies. Front Biosci 2010;2:701-10.
62. Kato M, Yamagata T, Kubota M, Arai H, Yamashita S, Nakagawa T, et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia 2013;54:1282.
63. Deprez L, Weckhuysen S, Holmgren P, Suls A, Van Dyck T, Goossens D, et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology 2010;75:1159-65.
64. Tohyama J, Akasaka N, Osaka H, Maegaki Y, Kato M, Saito N, et al. Early onset West syndrome with cerebral hypomyelination and reduced cerebral white matter. Brain Dev 2008;30: 349-55.
65. Saitsu H, Kato M, Okada I, Orii KE, Higuchi T, Hoshino H, et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. Epilepsia 2010;51: 2397-405.
66. Saitsu H, Tohyama J, Kumada T, Egawa K, Hamada K, Okada I, et al. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet 2010; 86:881-91.
67. Hamdan FF, Gauthier J, Dobrzeniecka S, Lortie A, Mottron L, Vanasse M, et al. Intellectual disability without epilepsy associated with STXBP1 disruption. Eur J Hum Genet 2011;19: 607-9.
68. Ogiwara I, Ito K, Sawaishi Y, Osaka H, Mazaki E, Inoue I, et al. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology 2009;73: 1046-53.
69. Kurian MA, Meyer E, Vassallo G, Morgan NV, Prakash N, Pasha S, et al. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain 2010;133: 2964-70.
70. Edvardson S, Baumann AM, MühlenhoffM, Stephan O, Kuss AW, Shaag A, et al. West syndrome caused by ST3Gal-III deficiency. Epilepsia 2013;54:e24-7.
71. Roche-Martinez A, Gerotina E, Armstrong-Moron J, Sans-Capdevila O. Pineda M [FOXG1, a new gene responsible for the congenital form of Rett syndrome]. Rev Neurol 2011;52: 597-602.
72. Striano P, Paravidino R, Sicca F, Chiurazzi P, Gimelli S, Coppola A, et al. West syndrome associated with 14q12 duplications harboring FOXG1. Neurology 2011;76:1600-2.
73. Tohyama J, Yamamoto T, Hosoki K, Nagasaki K, Akasaka N, Ohashi T, et al. West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14. Am J Med Genet A 2011;155A:2584-8.
74. Sobreira N, Walsh MF, Batista D, Wang T. Interstitial deletion 5q14.3-q21 associated with iris coloboma, hearing loss, dental anomaly, moderate intellectual disability, and attention deficit and hyperactivity disorder. Am J Med Genet A 2009;149A: 2581-3.
75. Le Meur N, Holder-Espinasse M, Jaillard S, Goldenberg A, Joriot S, Amati-Bonneau P, et al. MEF2 C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations. J Med Genet 2010;47:22-9.
76. Novara F, Beri S, Giorda R, Ortibus E, Nageshappa S, Darra F, et al. Refining the phenotype associated with MEF2C haploinsufficiency. Clin Genet 2010;78:471-7.
77. Zweier M, Gregor A, Zweier C, Engels H, Sticht H, Wohlleber E, et al. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum Mutat 2010;31:722-33.
78. Bienvenu T, Diebold B, Chelly J, Isidor B. Refining the phenotype associated with MEF2C point mutations. Neurogenetics 2013;14:71-5.
79. Ruggieri M, Iannetti P, Clementi M, Polizzi A, Incorpora G, Spalice A, et al. Neurofibromatosis 1and infantile spasms. Childs Nerv Syst 2009;25:211-6.
80. Topcu M, Saatci I, Haliloglu G, Kesimer M, Coskun T. Dglyceric aciduria in a six-month-old boy presenting with West syndrome and autistic behaviour. Neuropediatrics 2002;33(1): 47-50.
81. Marshall CR, Young EJ, Pani AM, FreckmannML, Lacassie Y, Howald C, et al. Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11. Am J Hum Genet 2008;83:106-11.
82. Nicita F, De Liso P, Denti FR, Papetti L, Ursitti F, Castronovo A, et al. The genetics of monogenic idiopathic epilepsies and epileptic encephalopathies. Seizure 2012;21:3-11.
83. Romano C, Tiné A, Fazio G, Rizzo R, Colognola RM, Sorge G, et al. Seizures in patients with trisomy 21. Am J Med Genet Suppl 1990;7:298-300.
84. Ruggieri M, Pascual-Catrovejo I, Di Rocco C. Neurocutaneous disorders: phakomatoses and hamartoneoplastic syndrome. Wein, New York: Springer ed.; 2008 p. 193.
85. Riikonen R. The latest on infantile spasms. Curr Opin Neurol 2005;18:91-5.
86. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion 2007. Epileptic Disord 2007;9:353-412.
87. Stafstrom CE, Arnason BG, Baram TZ, Catania A, Cortez MA, Glauser TA, et al. Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol 2011;26:1411-21.
88. Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, et al. The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-8.
89. Brodie SE. Screening for vigabatrin (sabril ®) retinal toxicity in children. Ophthalmic Genet 2011;32:193-5.
90. Pearl PL, Vezina LG, Saneto RP, Mc Carter R, Molloy-Welles E, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 2001;108:184-94.
91. Chandra S, Bhave A, Bhargava R, Kumar C, Kumar R. West syndrome: response to valproate. Front Neurol 2012;3: 166-71.
92. Pavone L, Incorpora G, La Rosa M, Li Volti S, Mollica F. Treatment of infantile spasms with sodium valproate acid. Dev Med Child Neurol 1981;23:454-61.
93. Siemes H, Spohr HL, Michael T, Nau H. Therapy of infantile spasms with valproate: results of a prospective study. Epilepsia 1988;29:553-60.
94. Prats JM, Garaizar C, Rua MJ, Garcia-Nieto ML, Madoz P. Infantile spasms treated with high doses of sodiumvalproate: initial response and follow-up. DevMed Child Neurol 1991;33: 617-25.
95. Suzuki Y. Zonisamide inWest syndrome. Brain Dev 2001;23: 658-61.
96. Peltzer B, Alonso WD, Porter BE. Topiramate and adrnocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol 2009;34:400-5.
97. Hosain SA, Merchant S, Solomon GE, Chutorian A. Topiramate for the treatment of infantile spasms. J Child Neurol 2006;21:17-9.
98. Raffo E, Coppola A, Ono T, Briggs SW, Galanopoulou AS. A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiol Dis 2011;43:322-9.
99. Chamberlain MC. Nitrazepam for refractory infantile spasms and the Lennox-Gastaut syndrome. J Child Neurol 1996;11:31-4.
100. Ohtsuka Y, Matsuda M, Ogino T, Kobayashi K, Ohtahara S. Treatment of the West syndrome with high-dose pyridoxal phosphate. Brain Dev 1987;9:418-21.
101. Tsao CY. Current trends in the treatment of infantile spams. Neuropsychiatr Dis Treat 2009;5:289-99.
102. Loddenkemper T, Holland KD, Stanford LD, Kotagal P, Bingaman W, Wyllie E. Developmental outcome after epilepsy surgery in infancy. Pediatrics 2007;119:930-5.
103. Pellock JM, Hrachovy R, Shinnar S, Baram TZ, Bettis D, Dlugos DJ, et al. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51:2175-89.
104. Hamano S, Yoshinari S, Higurashi N, Tanaka M, Minamitani M, Eto Y. Developmental outcomes of cryptogenic West syndrome. J Pediatr 2007;150:295-9.
105. Ito M, Kumagai T, Yamazaki Y, Sekijima K, Sakakibara K, Matsutomo Y, et al. Long-term prognosis of patients with West syndrome in Japan: medical aspects. Brain Dev 2001;23: 692-4.
106. Arce-Portillo E, Rufo-Campos M, Munoz-Cabello B, Blanco-Martinez B, Madruga-Garrido M, Ruiz-Del Portal L. West syndrome: aetiology, therapeutic options, clinical course and prognostic factors. Rev Neurol 2011;52:81-9.
107. Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013 Jun 24 (Epub ahead of print).
108. Curatolo P, Moavero R. MTOR inhibitors in tuberous sclerosis complex. Curr Neuropharmacol 2012;10:404-15.
109. Pavone P, Falsaperla R, Ruggieri M, Praticò AD, Pavone L. West syndrome treatment: new roads for an old syndrome. Front Neurol 2013;4:113.